Your browser doesn't support javascript.
loading
Vagal afferent cholecystokinin receptor activation is required for glucagon-like peptide-1-induced satiation.
Vana, Vasiliki; Laerke, Michelle K; Rehfeld, Jens F; Arnold, Myrtha; Dmytriyeva, Oksana; Langhans, Wolfgang; Schwartz, Thue W; Hansen, Harald S.
Afiliación
  • Vana V; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Laerke MK; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
  • Rehfeld JF; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Arnold M; Department of Clinical Biochemistry (KB3011), Rigshospitalet, Copenhagen, Denmark.
  • Dmytriyeva O; Physiology and Behavior Laboratory, Department of Health Sciences and Technology, ETH Zurich, Schwerzenbach, Switzerland.
  • Langhans W; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
  • Schwartz TW; Physiology and Behavior Laboratory, Department of Health Sciences and Technology, ETH Zurich, Schwerzenbach, Switzerland.
  • Hansen HS; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Diabetes Obes Metab ; 24(2): 268-280, 2022 02.
Article en En | MEDLINE | ID: mdl-34658116

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colecistoquinina / Péptido 1 Similar al Glucagón Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colecistoquinina / Péptido 1 Similar al Glucagón Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article